UK markets close in 48 minutes

Tate & Lyle plc (TATE.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
618.00-2.00 (-0.32%)
As of 03:27PM GMT. Market open.
Full screen
Previous close620.00
Open622.00
Bid617.00 x 0
Ask618.00 x 0
Day's range615.50 - 622.50
52-week range587.00 - 837.50
Volume187,126
Avg. volume1,460,068
Market cap2.482B
Beta (5Y monthly)0.49
PE ratio (TTM)14.37
EPS (TTM)0.43
Earnings date23 May 2024
Forward dividend & yield0.19 (3.11%)
Ex-dividend date23 Nov 2023
1y target est884.00
  • Simply Wall St.

    Tate & Lyle (LON:TATE) Hasn't Managed To Accelerate Its Returns

    If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

  • Reuters

    UPDATE 2-Sweetener maker Tate & Lyle warns of lower annual revenue on softer demand

    British food ingredients maker Tate & Lyle on Wednesday forecast its annual revenue would fall "slightly" from the previous year, pointing to softer demand and persistent de-stocking by customers. "In Food & Beverage Solutions, volume and revenue were lower ... due to a combination of softer consumer demand and customer de-stocking ... and some customers phasing orders into the fourth quarter when new calendar year contracts, which included the pass-through of input cost deflation, came into effect," CEO Nick Hampton said in a statement. A rush to stock up on ingredients during the pandemic and higher prices due to inflation had helped lift revenue for many companies but volumes have fallen over the past year as customers use up stock.

  • Reuters

    Sweetener maker Tate & Lyle warns of lower annual revenue on softer demand

    "In Food & Beverage Solutions, volume and revenue were lower ... due to a combination of softer consumer demand and customer de-stocking ... and some customers phasing orders into the fourth quarter when new calendar year contracts, which included the pass-through of input cost deflation, came into effect," CEO Nick Hampton said in a statement. A rush to stock up on ingredients during the pandemic and higher prices due to inflation had helped lift revenue for many companies but volumes have fallen over the past year as customers use up stock. Tate & Lyle, which supplies ingredients for Splenda, the sweetener in Diet Coke and other sugar-free drinks, retained its annual core profit growth forecast of 7% to 9% for the year to end-March.